Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for NexGel, Inc. (NXGL : NSDQ)

• Company Description    NexGel Inc. is a provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. The company developed and manufactured electron-beam, cross-linked hydrogels. NexGel Inc. is based in Langhorne, Pa. Number of Employees: 19

• Price / Volume Information    Yesterday's Closing Price: $2.37 Daily Weekly Monthly 20 Day Moving Average: 66,375 shares Shares Outstanding: 8.14 (millions) Market Capitalization: $19.30 (millions) Beta: 0.57 52 Week High: $5.10 52 Week Low: $2.10 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -12.55% -13.09% 12 Week -1.25% -6.04% Year To Date -46.86% -54.01%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2150 Cabot Blvd West Suite B - LANGHORNE,PA 19047 USA ph: 215-702-8550 fax: - valter@kcsa.com https://nexgel.com

• General Corporate Information    Officers Adam Levy - Chief Executive Officer and President Joseph F. McGuire - Chief Financial Officer Steven Glassman - Director Scott Henry - Director Nachum Stein - Director Peer Information NexGel, Inc. (ABMD) NexGel, Inc. (DMDS) NexGel, Inc. (CPWY.) NexGel, Inc. (EQUR) NexGel, Inc. (ECIA) NexGel, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 65344E107 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/11/25 Share - Related Items Shares Outstanding: 8.14 Most Recent Split Date: (:1) Beta: 0.57 Market Capitalization: $19.30 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.59 Price/Cash Flow: - Price / Sales: 1.65 EPS Growth vs. Year Ago Period: 35.71% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 100.28% vs. Previous Quarter: 2.78% ROE 09/30/25 - - 06/30/25 - -49.37 03/31/25 - -54.95 ROA 09/30/25 - - 06/30/25 - -25.68 03/31/25 - -27.84 Current Ratio 09/30/25 - - 06/30/25 - 1.74 03/31/25 - 1.88 Quick Ratio 09/30/25 - - 06/30/25 - 0.98 03/31/25 - 1.15 Operating Margin 09/30/25 - - 06/30/25 - -22.94 03/31/25 - -28.42 Net Margin 09/30/25 - - 06/30/25 - -25.02 03/31/25 - -30.80 Pre-Tax Margin 09/30/25 - - 06/30/25 - -24.82 03/31/25 - -31.64 Book Value 09/30/25 - - 06/30/25 - 0.66 03/31/25 - 0.73 Inventory Turnover 09/30/25 - - 06/30/25 - 3.85 03/31/25 - 3.78 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.16 03/31/25 - 0.15 Debt-to-Capital 09/30/25 - - 06/30/25 - 13.87 03/31/25 - 13.32

Powered by Zacks Investment Research ©